- Research news
- Open Access
Making sense of antisense
© BioMed Central Ltd 2001
- Published: 08 March 2001
- Candida Albicans
- Antifungal Drug
- Insertional Mutagenesis
- Yeast Growth
- Growth Phenotype
The yeast Candida albicans is the major pathogen causing human fungal infections. C. albicans is not amenable to functional genomic strategies used for other micro-organisms, because of mating difficulties, its diploid nature and the lack of random insertional mutagenesis methods.
In the March Nature Biotechnology, Marianne De Backer and colleagues describe an approach to overcoming these limitations, in order to perform a genome-wide screen for gene function (Nature Biotechnology 2001, 19:235-241). The technique combines antisense RNA and promoter interference technology and involves the development of an integrative vector to drive transcription of antisense RNA in an inducible manner.
De Backer et al created a library of clonedC. albicansDNA fragments, introduced these into C. albicans and screened for the effects of gene suppression on yeast growth. About 10% of transformants showed a growth phenotype and it was possible to identify 86 different genes, of which 38% have no homologues in other organisms.
They also showed that these crippled strains could be used effectively in high-throughput screening assays to identify possible antifungal drugs. This is because reduced expression of a gene renders the yeast more sensitive to drugs that act on its protein product or associated molecules in the same pathway.
- An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans.Google Scholar
- Nature Biotechnology, [http://www.nature.com/nbt/]
- Candida albicans sequence at Stanford University, [http://www-sequence.stanford.edu/group/candida/index.html]